- Corporate Officers - A
- Altomari Alfred
Insider Trading History of Altomari Alfred
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Altomari Alfred since 2007.
This trader's CIK number is 1285644.
At the time of last reporting, Altomari Alfred was the Chief Executive Officer of Agile Therapeutics Inc. (stock ticker symbol AGRX).
Also see all insider trading activities at Agile Therapeutics Inc.
Note that in the past
ALTOMARI ALFRED also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Auxilium Pharmaceuticals Inc (AUXL) by Altomari Alfred
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | AUXL | 0 | $0 | 15,000 | $199,890 | 15,000 | $90,900 |
Yearly summary of insider trading at Societal Cdmo, Inc. (REPH) by Altomari Alfred
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | REPH | 0 | $0 | 0 | $0 | 13,274 | $0 |
| 2016 | REPH | 1,500 | $9,825 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Dusa Pharmaceuticals Inc (DUSA) by Altomari Alfred
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | DUSA | 2,000 | $8,119 | 0 | $0 | 0 | $0 |
| 2010 | DUSA | 2,000 | $5,040 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Insmed Inc (INSM) by Altomari Alfred
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | INSM | 0 | $0 | 20,000 | $791,400 | 0 | $0 |
| 2019 | INSM | 0 | $0 | 22,000 | $577,500 | 0 | $0 |
| 2014 | INSM | 0 | $0 | 0 | $0 | 8,955 | $0 |
| 2013 | INSM | 0 | $0 | 0 | $0 | 4,327 | $0 |
Yearly summary of insider trading at Baudax Bio, Inc. (BXRX) by Altomari Alfred
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | BXRX | 5,000 | $11,700 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Agile Therapeutics Inc (AGRX) by Altomari Alfred
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | AGRX | 50,000 | $22,500 | 0 | $0 | 0 | $0 |
| 2021 | AGRX | 117,524 | $90,314 | 0 | $0 | 0 | $0 |
| 2020 | AGRX | 10,000 | $27,100 | 0 | $0 | 161,140 | $266,238 |
| 2019 | AGRX | 45,000 | $63,900 | 0 | $0 | 35,314 | $0 |
| 2018 | AGRX | 0 | $0 | 0 | $0 | 16,667 | $0 |
| 2017 | AGRX | 20,000 | $68,500 | 0 | $0 | 46,667 | $52,800 |
| 2016 | AGRX | 0 | $0 | 0 | $0 | 16,666 | $0 |
| 2015 | AGRX | 2,500 | $21,825 | 0 | $0 | 17,500 | $30,800 |
| 2014 | AGRX | 0 | $0 | 0 | $0 | 30,000 | $52,800 |
Insider trading activities at 6 companies by Altomari Alfred:
1. Auxilium Pharmaceuticals Inc (AUXL)
2. Societal Cdmo, Inc. (REPH)
3. Dusa Pharmaceuticals Inc (DUSA)
4. Insmed Inc (INSM)
5. Baudax Bio, Inc. (BXRX)
6. Agile Therapeutics Inc (AGRX)
Table 1. Insider trading of Auxilium Pharmaceuticals Inc (AUXL) by Altomari Alfred
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-05-08 | AUXL | Option Ex | 15,000 | 6.06 | 90,900 |
| 2007-05-08 | AUXL | Sale | 15,000 | 13.33 | 199,890 |
Table 2. Insider trading of Societal Cdmo, Inc. (REPH) by Altomari Alfred
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-12 | REPH | Option Ex | 13,274 | .00 | 0 |
| 2016-12-15 | REPH | Buy | 1,500 | 6.55 | 9,825 |
Table 3. Insider trading of Dusa Pharmaceuticals Inc (DUSA) by Altomari Alfred
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-08-11 | DUSA | Buy | 2,000 | 4.06 | 8,119 |
| 2010-08-05 | DUSA | Buy | 2,000 | 2.52 | 5,040 |
Table 4. Insider trading of Insmed Inc (INSM) by Altomari Alfred
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-12-07 | INSM | Sale | 20,000 | 39.57 | 791,400 |
| 2019-02-26 | INSM | Sale | 5,500 | 30.00 | 165,000 |
| 2019-02-15 | INSM | Sale | 5,500 | 27.50 | 151,250 |
| 2019-02-05 | INSM | Sale | 5,500 | 25.00 | 137,500 |
| 2019-01-10 | INSM | Sale | 5,500 | 22.50 | 123,750 |
| 2014-01-11 | INSM | Option Ex | 8,955 | .00 | 0 |
| 2013-08-02 | INSM | Option Ex | 4,327 | .00 | 0 |
Table 5. Insider trading of Baudax Bio, Inc. (BXRX) by Altomari Alfred
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-26 | BXRX | Buy | 5,000 | 2.34 | 11,700 |
Table 6. Insider trading of Agile Therapeutics Inc (AGRX) by Altomari Alfred
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-08-26 | AGRX | Buy | 50,000 | .45 | 22,500 |
| 2021-10-13 | AGRX | Buy | 58,824 | .00 | 0 |
| 2021-07-29 | AGRX | Buy | 26,200 | 1.26 | 33,090 |
| 2021-05-18 | AGRX | Buy | 20,000 | 1.61 | 32,200 |
| 2021-03-23 | AGRX | Buy | 12,500 | 2.00 | 25,024 |
| 2020-08-20 | AGRX | Option Ex | 94,599 | 1.76 | 166,494 |
| 2020-06-22 | AGRX | Option Ex | 50,000 | 1.76 | 88,000 |
| 2020-02-27 | AGRX | Buy | 10,000 | 2.71 | 27,100 |
| 2020-02-27 | AGRX | Option Ex | 16,541 | .71 | 11,744 |
| 2019-06-10 | AGRX | Buy | 20,000 | 1.27 | 25,400 |
| 2019-03-25 | AGRX | Buy | 25,000 | 1.54 | 38,500 |
| 2019-01-24 | AGRX | Option Ex | 35,314 | .00 | 0 |
| 2018-02-08 | AGRX | Option Ex | 16,667 | .00 | 0 |
| 2017-08-25 | AGRX | Buy | 10,000 | 3.34 | 33,400 |
| 2017-05-11 | AGRX | Buy | 10,000 | 3.51 | 35,100 |
| 2017-04-11 | AGRX | Option Ex | 30,000 | 1.76 | 52,800 |
| 2017-02-08 | AGRX | Option Ex | 16,667 | .00 | 0 |
| 2016-02-08 | AGRX | Option Ex | 16,666 | .00 | 0 |
| 2015-06-02 | AGRX | Buy | 2,500 | 8.73 | 21,825 |
| 2015-03-11 | AGRX | Option Ex | 17,500 | 1.76 | 30,800 |
| 2014-12-18 | AGRX | Option Ex | 30,000 | 1.76 | 52,800 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Altomari Alfred
(Chief Executive Officer of Agile Therapeutics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.